Pan‐Fen Wang

1.3k total citations
25 papers, 1.1k citations indexed

About

Pan‐Fen Wang is a scholar working on Molecular Biology, Pharmacology and Cell Biology. According to data from OpenAlex, Pan‐Fen Wang has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Cell Biology. Recurrent topics in Pan‐Fen Wang's work include Pharmacogenetics and Drug Metabolism (6 papers), Muscle metabolism and nutrition (5 papers) and Sulfur Compounds in Biology (4 papers). Pan‐Fen Wang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Muscle metabolism and nutrition (5 papers) and Sulfur Compounds in Biology (4 papers). Pan‐Fen Wang collaborates with scholars based in United States, China and Germany. Pan‐Fen Wang's co-authors include Charles H. Williams, Rongliang Zheng, Michael J. McLeish, George L. Kenyon, Donna M. Veine, L. David Arscott, Sylke Müller, Evan D. Kharasch, Patricia C. Babbitt and Martha Ludwig and has published in prestigious journals such as Biochemistry, Journal of Bacteriology and European Journal of Biochemistry.

In The Last Decade

Pan‐Fen Wang

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pan‐Fen Wang United States 17 684 141 124 114 98 25 1.1k
Sohei Ito Japan 24 993 1.5× 129 0.9× 160 1.3× 106 0.9× 144 1.5× 78 1.6k
Sean V. Taylor United States 23 1.2k 1.8× 118 0.8× 268 2.2× 64 0.6× 212 2.2× 56 2.0k
Catalin E. Doneanu United States 24 945 1.4× 95 0.7× 137 1.1× 135 1.2× 71 0.7× 46 1.5k
Elizabeth M. Ellis United Kingdom 21 826 1.2× 122 0.9× 182 1.5× 439 3.9× 112 1.1× 36 1.6k
Denis Tritsch France 23 1.5k 2.2× 164 1.2× 136 1.1× 92 0.8× 77 0.8× 64 2.0k
Florian Kaiser Germany 12 788 1.2× 323 2.3× 128 1.0× 44 0.4× 45 0.5× 24 1.5k
Jan A. Gliński United States 19 482 0.7× 177 1.3× 156 1.3× 43 0.4× 63 0.6× 44 1.1k
Mikio Fujii Japan 23 1.1k 1.6× 213 1.5× 197 1.6× 32 0.3× 45 0.5× 73 1.7k
Chandralal M. Hewage Ireland 22 996 1.5× 87 0.6× 293 2.4× 50 0.4× 38 0.4× 69 1.7k
Thomas Scior Mexico 20 957 1.4× 381 2.7× 92 0.7× 86 0.8× 23 0.2× 73 1.8k

Countries citing papers authored by Pan‐Fen Wang

Since Specialization
Citations

This map shows the geographic impact of Pan‐Fen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan‐Fen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan‐Fen Wang more than expected).

Fields of papers citing papers by Pan‐Fen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan‐Fen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan‐Fen Wang. The network helps show where Pan‐Fen Wang may publish in the future.

Co-authorship network of co-authors of Pan‐Fen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pan‐Fen Wang. A scholar is included among the top collaborators of Pan‐Fen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan‐Fen Wang. Pan‐Fen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Pan‐Fen, et al.. (2023). Natural Products Inhibition of Cytochrome P450 2B6 Activity and Methadone Metabolism. Drug Metabolism and Disposition. 52(3). 252–265. 1 indexed citations
2.
Wang, Pan‐Fen, et al.. (2022). Methadone pharmacogenetics in vitro and in vivo: Metabolism by CYP2B6 polymorphic variants and genetic variability in paediatric disposition. British Journal of Clinical Pharmacology. 88(11). 4881–4893. 8 indexed citations
3.
Wang, Pan‐Fen, et al.. (2020). Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants. Drug Metabolism and Disposition. 48(6). 438–445. 14 indexed citations
4.
Wang, Pan‐Fen, et al.. (2019). Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry. Drug Metabolism and Disposition. 47(10). 1195–1205. 34 indexed citations
5.
Wang, Pan‐Fen, et al.. (2018). Halogen Substitution Influences Ketamine Metabolism by Cytochrome P450 2B6: In Vitro and Computational Approaches. Molecular Pharmaceutics. 16(2). 898–906. 26 indexed citations
6.
Mosberg, Joshua A., Alejandra Yep, Timothy C. Meredith, et al.. (2011). A Unique Arabinose 5-Phosphate Isomerase Found within a Genomic Island Associated with the Uropathogenicity of Escherichia coli CFT073. Journal of Bacteriology. 193(12). 2981–2988. 8 indexed citations
7.
Wang, Pan‐Fen, Alejandra Yep, George L. Kenyon, & Michael J. McLeish. (2008). Using directed evolution to probe the substrate specificity of mandelamide hydrolase. Protein Engineering Design and Selection. 22(2). 103–110. 4 indexed citations
8.
Wang, Pan‐Fen, George L. Kenyon, & Michael J. McLeish. (2006). Heterogeneity of Escherichia coli -expressed human muscle creatine kinase. IUBMB Life. 58(7). 421–428. 2 indexed citations
9.
Wang, Pan‐Fen, Allen Flynn, Michael J. McLeish, & George L. Kenyon. (2005). Loop Movement and Catalysis in Creatine Kinase. IUBMB Life. 57(4-5). 355–362. 8 indexed citations
10.
Novak, Walter R. P., Pan‐Fen Wang, Michael J. McLeish, George L. Kenyon, & Patricia C. Babbitt. (2004). Isoleucine 69 and Valine 325 Form a Specificity Pocket in Human Muscle Creatine Kinase. Biochemistry. 43(43). 13766–13774. 28 indexed citations
11.
Wang, Pan‐Fen, et al.. (2002). Expression of Torpedo californica creatine kinase in Escherichia coli and purification from inclusion bodies. Protein Expression and Purification. 26(1). 89–95. 7 indexed citations
12.
Novak, Walter R. P., et al.. (2001). Mutagenesis of Two Acidic Active Site Residues in Human Muscle Creatine Kinase:  Implications for the Catalytic Mechanism. Biochemistry. 40(10). 3056–3061. 30 indexed citations
13.
Williams, Charles H., L. David Arscott, Sylke Müller, et al.. (2000). Thioredoxin reductase. European Journal of Biochemistry. 267(20). 6110–6117. 273 indexed citations
14.
Wang, Pan‐Fen, L. David Arscott, Tim‐Wolf Gilberger, Sylke Müller, & Charles H. Williams. (1999). Thioredoxin Reductase from Plasmodium falciparum:  Evidence for Interaction between the C-Terminal Cysteine Residues and the Active Site Disulfide−Dithiol. Biochemistry. 38(10). 3187–3196. 49 indexed citations
15.
16.
Wang, Pan‐Fen, et al.. (1996). Scavenging effects of phenylpropanoid glycosides from Pedicularis on superoxide anion and hydroxyl radical by the Spin trapping method(95)02255-4. Biochemical Pharmacology. 51(5). 687–691. 89 indexed citations
17.
Wang, Pan‐Fen, et al.. (1996). A Stable Mixed Disulfide between Thioredoxin Reductase and Its Substrate, Thioredoxin:  Preparation and Characterization. Biochemistry. 35(15). 4812–4819. 61 indexed citations
18.
Wang, Pan‐Fen, et al.. (1994). Making vitamin C lipo-soluble enhances its protective effect against radical induced hemolysis of erythrocytes. Chemistry and Physics of Lipids. 71(1). 95–97. 37 indexed citations
19.
Zheng, Rongliang, Pan‐Fen Wang, Ji Li, Zimin Liu, & Zhong‐Jian Jia. (1993). Inhibition of the autoxidation of linoleic acid by phenylpropanoid glycosides from Pedicularis in micelles. Chemistry and Physics of Lipids. 65(2). 151–154. 32 indexed citations
20.
Wang, Pan‐Fen & Rongliang Zheng. (1992). Inhibitions of the autoxidation of linoleic acid by flavonoids in micelles. Chemistry and Physics of Lipids. 63(1-2). 37–40. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sohei Ito Breakdown of academic impact, for papers by Sean V. Taylor Breakdown of academic impact, for papers by Catalin E. Doneanu Breakdown of academic impact, for papers by Elizabeth M. Ellis Breakdown of academic impact, for papers by Denis Tritsch Breakdown of academic impact, for papers by Florian Kaiser Breakdown of academic impact, for papers by Jan A. Gliński Breakdown of academic impact, for papers by Mikio Fujii Breakdown of academic impact, for papers by Chandralal M. Hewage Breakdown of academic impact, for papers by Thomas Scior
Rankless by CCL
2026